Keck School Faculty

Anne Kathryn Schuckman, MD
Anne Kathryn Schuckman, MD
Assistant Professor of Clinical Urology
NOR 7416 Health Sciences Campus Los Angeles
Dr. Anne Schuckman graduated from Stanford University, and completed her medical training at the University of Southern California School of Medicine. She completed her residency training at LAC+USC Medical Center and her fellowship in urologic oncology under Dr. Donald Skinner at USC Norris Comprehensive Cancer Center.

Dr. Schuckman’s areas if interest include testicular cancer, bladder cancer and urinary reconstruction. She performs both open and laparoscopic procedures, including laparoscopic nephrectomy and partial nephrectomy.

American Urological Association: Murphy Scholar, 2006

Assessing trends in urinary diversion after radical cystectomy for bladder cancer in the United StatesUrol Oncol. 2019 03; 37(3):180. e1-180. e9. . View in PubMed

Factors influencing ICU admission and associated outcome in patients undergoing radical cystectomy with enhanced recovery pathwayUrol Oncol. 2019 Sep; 37(9):572. e13-572. e19. . View in PubMed

Surgical approach as a determinant factor of clinical outcome following radical cystectomy: Does Enhanced Recovery After Surgery (ERAS) level the playing field? Urol Oncol. 2019 Oct; 37(10):765-773.. View in PubMed

Factors influencing intraoperative conversion from planned orthotopic to non-orthotopic urinary diversion during radical cystectomy World J Urol. 2019 Sep; 37(9):1851-1855. . View in PubMed

Assessing the Impact of Time to Cystectomy for Variant Histology of Urothelial Bladder Cancer Urology. 2019 11; 133:157-163. . View in PubMed

Extended hospital stay after radical cystectomy with enhanced recovery protocol Can J Urol. 2019 02; 26(1):9654-9659. . View in PubMed

Frailty as a predictor of complications after radical cystectomy: A prospective study of various preoperative assessments Urol Oncol. 2019 01; 37(1):40-47. . View in PubMed

Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer Urol Oncol. 2019 01; 37(1):1-11. . View in PubMed

National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013 Eur Urol Oncol. 2018 Dec 19. . View in PubMed

The impact of patient-related nonmodifiable factors on perioperative outcomes following radical cystectomy with enhanced recovery protocol Ther Adv Urol. 2018 Dec; 10(12):393-401. . View in PubMed

The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol World J Urol. 2018 Mar; 36(3):401-407. . View in PubMed

Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol Eur Urol Focus. 2018 12; 4(6):889-894. . View in PubMed

Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy Can Urol Assoc J. 2017 Oct; 11(10):331-336. . View in PubMed

Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients Clin Genitourin Cancer. 2017 Sep 06. . View in PubMed

Current Management Strategy for Penile Cancer and Future Directions Curr Oncol Rep. 2017 Aug; 19(8):54. . View in PubMed

90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study World J Urol. 2017 Jun; 35(6):907-911. . View in PubMed

Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer Eur Urol Focus. 2016 Apr; 2(1):92-96. . View in PubMed

Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire J Urol. 2016 12; 196(6):1685-1691. . View in PubMed

Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile CancerClin Genitourin Cancer. 2016 10; 14(5):450-456. e1. . View in PubMed

Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway J Urol. 2015 Nov; 194(5):1209-13. . View in PubMed

Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy World J Urol. 2015 Oct; 33(10):1397-402. . View in PubMed

Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience Urology. 2015 Jul; 86(1):87-91. . View in PubMed

Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events J Urol. 2015 Feb; 193(2):565-9. . View in PubMed

Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy Urology. 2014 Dec; 84(6):1420-6. . View in PubMed

Significance of perivesical lymph nodes in radical cystectomy for bladder cancer Urol Oncol. 2014 Nov; 32(8):1158-65. . View in PubMed

Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA Nat Rev Urol. 2014 Oct; 11(10):589-96. . View in PubMed

Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control J Urol. 2014 Sep; 192(3):682-8. . View in PubMed

Enhanced recovery protocol after radical cystectomy for bladder cancer J Urol. 2014 Jul; 192(1):50-5. . View in PubMed

Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the Western United States Clin Genitourin Cancer. 2014 Apr; 12(2):138-42. . View in PubMed

Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy Urol Oncol. 2014 Feb; 32(2):110-6. . View in PubMed

Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era Urol Oncol. 2014 Feb; 32(2):85-91. . View in PubMed

Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patientsUrol Oncol. 2014 Jan; 32(1):52. e1-9. . View in PubMed

The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder PLoS One. 2014; 9(8):e105326. . View in PubMed

Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases Urology. 2014 Jan; 83(1):159-65. . View in PubMed

Neoadjuvant chemotherapy with gemcitabine/cisplatin vsmethotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urol Oncol. 2013 Nov; 31(8):1737-43. . View in PubMed

Factors influencing post-recurrence survival in bladder cancer following radical cystectomy BJU Int. 2012 Mar; 109(6):846-54. . View in PubMed

Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-728.. View in PubMed

Surgical considerations for elderly urologic oncology patients Urol Oncol. 2009 Nov-Dec; 27(6):628-32. . View in PubMed

Powered by SC CTSI
Go to Top